Healthcare - Biotechnology - NASDAQ - US
$ 3.69
0.545 %
$ 5.69 M
Market Cap
-1.21
P/E
CASH FLOW STATEMENT
-4.11 M
OPERATING CASH FLOW
0
INVESTING CASH FLOW
0
FINANCING CASH FLOW
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Xenetic Biosciences, Inc.
| Net Income | -4.13 M |
| Depreciation & Amortization | 0 |
| Capital Expenditures | 0 |
| Stock-Based Compensation | 283 K |
| Change in Working Capital | -263 K |
| Others | 845 |
| Free Cash Flow | -4.11 M |
Cash Flow
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | Dec-2014 | Dec-2013 | Dec-2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| OPERATING CASH FLOW | ||||||||||||
| Net Income | (4.1) | (6.6) | (5.6) | (10.9) | (12.8) | (7.3) | (3.6) | (54.2) | (12.5) | (14.3) | (8.6) | (6.3) |
| Depreciation & Amortization | 0 | 27 K | 35.5 K | 28.8 K | 27.5 K | 15.8 K | 23.8 K | 36.4 K | 56.1 K | 88.7 K | 52 K | 0.1 |
| Deferred Income Tax | 0 | 0 | 24.3 K | (2.9) | 3.3 | 0 | 0 | (1.6) | 2.6 | 0.6 | (0.4) | 1.0 |
| Stock Based Compensation | 0.3 | 0.5 | 0.4 | 0.5 | 0.9 | 1.4 | 1.9 | 2.1 | 2.7 | 1.5 | 0.4 | 0.3 |
| Other Operating Activities | 0 | 1.8 | 24.3 K | 9.1 | 3.0 | 5.23 K | (0.1) | 49.1 | 0.8 | 0.2 | 0.4 | 51.2 K |
| Change in Working Capital | (0.3) | (0.4) | 0.5 | 52.4 K | (0.9) | (0.6) | 3.3 | (4.3) | 1.0 | (0.5) | 2.1 | (1.5) |
| Cash From Operations | (4.1) | (4.6) | (4.7) | (4.3) | (6.4) | (6.5) | 1.5 | (8.8) | (5.3) | (12.3) | (6.1) | (6.3) |
| INVESTING CASH FLOW | ||||||||||||
| Capital Expenditures | 0 | (0.5) | 0 | 0 | 0 | 0 | 9.26 K | 16.8 K | 1.66 K | 57.7 K | 78.6 K | (0.1) |
| Other Items | 0 | 0 | 0 | 0 | 2 K | 22.5 K | 0 | 0 | 7.88 K | 5.49 K | 66 K | 37.5 K |
| Cash From Investing Activities | 0 | (0.5) | 0 | 0 | 2 K | 22.5 K | 9.26 K | 16.8 K | 6.22 K | 52.2 K | (0.1) | 92.6 K |
| FINANCING CASH FLOW | ||||||||||||
| Common Stock Repurchased | 0 | 1.3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Debt Repaid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3.7 | 3.0 | 0 | 0 | (0.7) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 16 | 0 | 3.68 K | 0 | 6.21 K | 1.5 | 125 | 9.0 | 0 | 9.8 | 2.09 K | 18.3 K |
| Cash From Financing Activities | 0 | 0 | 11.5 | 5.4 | 16.1 | 1.5 | 125 | 12.7 | 3.0 | 9.8 | 2.09 K | (0.3) |
| CHANGE IN CASH | ||||||||||||
| Net Change In Cash | (4.1) | (5.1) | 6.7 | 1.2 | 9.7 | (5.0) | 1.5 | 3.9 | (2.4) | (2.3) | (6.3) | (6.0) |
| FREE CASH FLOW | ||||||||||||
| Free Cash Flow | (4.1) | (5.1) | (4.7) | (4.3) | (6.4) | (6.5) | 1.5 | (8.8) | (5.3) | (12.4) | (6.1) | (6.4) |